BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 3985219)

  • 1. Stelazine advertisement "dismays" readers.
    Swartz M; Taska R; Hargett A; Noll B; Fraker W
    Am J Psychiatry; 1985 May; 142(5):666. PubMed ID: 3985219
    [No Abstract]   [Full Text] [Related]  

  • 2. [Borderline states].
    Kringlen E
    Ann Med Psychol (Paris); 1986 Jun; 144(6):559-62. PubMed ID: 3813339
    [No Abstract]   [Full Text] [Related]  

  • 3. [Borderline personality disorders--current development of the concept].
    Czernikiewicz A
    Psychiatr Pol; 1986; 20(3):225-31. PubMed ID: 3541018
    [No Abstract]   [Full Text] [Related]  

  • 4. Effect of tranquilizers on borderline and schizotypal patients questioned.
    Rockland LH
    Am J Psychiatry; 1985 May; 142(5):665-6. PubMed ID: 3885764
    [No Abstract]   [Full Text] [Related]  

  • 5. Borderline and schizotypal personality disorders treated with low-dose thiothixene vs placebo.
    Goldberg SC; Schulz SC; Schulz PM; Resnick RJ; Hamer RM; Friedel RO
    Arch Gen Psychiatry; 1986 Jul; 43(7):680-6. PubMed ID: 3521531
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychopharmacologic approaches to borderline syndromes.
    Ellison JM; Adler DA
    Compr Psychiatry; 1984; 25(3):255-62. PubMed ID: 6145542
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacotherapy for patients with borderline personality disorder.
    Gunderson JG
    Arch Gen Psychiatry; 1986 Jul; 43(7):698-700. PubMed ID: 2872871
    [No Abstract]   [Full Text] [Related]  

  • 8. Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine.
    Cowdry RW; Gardner DL
    Arch Gen Psychiatry; 1988 Feb; 45(2):111-9. PubMed ID: 3276280
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial transmission of schizotypal and borderline personality disorders.
    Baron M; Gruen R; Asnis L; Lord S
    Am J Psychiatry; 1985 Aug; 142(8):927-34. PubMed ID: 4025588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confusing borderline schizophrenia with borderline personality disorder.
    Brounstein DA
    J Pers Assess; 1982 Oct; 46(5):560. PubMed ID: 7143196
    [No Abstract]   [Full Text] [Related]  

  • 11. Borderline and schizotypal personality disorders: mutually exclusive or overlapping?
    Serban G; Conte HR; Plutchik R
    J Pers Assess; 1987; 51(1):15-22. PubMed ID: 3572708
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Schizotypal symptoms in patients with borderline personality disorders.
    George A; Soloff PH
    Am J Psychiatry; 1986 Feb; 143(2):212-5. PubMed ID: 3946657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The interaction of psychopharmacology and psychoanalysis in the borderline patient.
    Snyder S
    Psychiatr Q; 1980; 52(4):240-50. PubMed ID: 6113616
    [No Abstract]   [Full Text] [Related]  

  • 14. Difference in reaction time between subjects with schizotypal and borderline personality disorders.
    Chapin K; Wightman L; Lycaki H; Josef N; Rosenbaum G
    Am J Psychiatry; 1987 Jul; 144(7):948-50. PubMed ID: 3605409
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Borderline syndrome, neuroses and personality disorders. A comparative study based on research-oriented criteria for borderline schizophrenia].
    Sass H; Koehler K
    Nervenarzt; 1982 Sep; 53(9):519-23. PubMed ID: 7133252
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinico-pharmacological characteristics of combined administration of tranquilizing agents and other psychotropic drugs].
    AleksandrovskiÄ­ IuA; Neznamov GG; TarnavskiÄ­ IuB; Valueva LN; Sigunova EA
    Farmakol Toksikol; 1982; 45(3):36-41. PubMed ID: 7095127
    [No Abstract]   [Full Text] [Related]  

  • 17. Borderline personality disorder: symptomatology and MMPI characteristics.
    Resnick RJ; Schulz P; Schulz SC; Hamer RM; Friedel RO; Goldberg SC
    J Clin Psychiatry; 1983 Aug; 44(8):289-92. PubMed ID: 6874649
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A critical examination of empirical studies of the diagnosis of borderline disorders in adults.
    Dahl AA
    Psychiatr Dev; 1985; 3(1):1-29. PubMed ID: 4001119
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Limits and uncertainties of borderline states. The example of drug addictions].
    Bourgeois M; Rager P; Peyre F
    Ann Med Psychol (Paris); 1986 Jun; 144(6):568-76. PubMed ID: 3545009
    [No Abstract]   [Full Text] [Related]  

  • 20. The significance of borderline and schizotypal overlap.
    Plakun EM; Muller JP; Burkhardt PE
    Hillside J Clin Psychiatry; 1987; 9(1):47-54. PubMed ID: 3653842
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.